|
David L. Dolinger, Ph.D. has been invited to give a talk at the Q1 Productions Quality in Diagnostic Development and Manufacturing Conference
The event takes place June 22nd and 23rd at the Hyatt Regency in Chicago. Dr. Dolinger will be talking about “Implementing Successful Design Controls in the Initial Stages of IVD Product Development”.
While quality systems and manufacturing operations often work in silos, focusing on the immediate importance of their positions, bring these groups together with R&D at the onset of production will ensure design controls meet quality standards from the outset of production.
About IntelligentMDx
IntelligentMDx’s mission is to make FDA approved diagnostic kits. To guarantee quality for customers and partners, we design, develop and manufacture tests under FDA Quality System Regulations and ISO 13485:2003 guidelines. These tests have been, and will be, designed to run on a broad range of molecular systems for clinical diagnostics, drug development and applied sciences.
IntelligentMDx designs, develops and commercializes clinically impactful molecular diagnostic tests. Our goal is to support clinicians in their efforts to provide care with certainty. Our commercial offerings include emerging and re-emerging infectious threats and are available for use in CLIA laboratories covering the rapidly growing markets for transplant and health care-associated infections. IntelligentMDx’s expertise spans evolutionary biology, bioinformatics, and wet lab/molecular biology capabilities, harnessed by our proprietary product development process allowing for the rapid design and development of tests to meet clinical needs.
Media Contact:
For more information on IntelligentMDx, visit www.IntelligentMDx.com or contact Corporate Communications at cc@IntelligentMDx.com, 617-871-6400.
|